DSTL Among Value ETFs
End-of-day Nov 16, 2026 · 77 Value ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −0.1% | +4.3% | +4.2% | +21.2% | +24.8% | +66.8% | +70.9% | +218.3% |
| Peer average | −1.1% | −0.8% | +1.0% | −0.3% | +17.9% | +21.8% | +75.4% | +69.3% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$21 of every $1,000 in DSTL is Accenture
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ACNAccenture | Technology | 2.11% | $211.16 | 185K | $46.4M |
| 2 | ABBVAbbVie | Healthcare | 2.00% | $200.41 | 149K | $44.0M |
| 3 | UNHUnitedHealth Group | Healthcare | 2.00% | $200.38 | 108K | $44.0M |
| 4 | MRKMerck | Healthcare | 1.86% | $186.47 | 277K | $41.0M |
| 5 | CMCSAComcast | Communication Services | 1.84% | $184.02 | 1.6M | $40.4M |
| 6 | CRMSalesforce | Technology | 1.76% | $175.90 | 177K | $38.6M |
| 7 | MPCMarathon Petroleum | Energy | 1.65% | $165.16 | 87K | $36.3M |
| 8 | LOWLowe's Cos | Consumer Cyclical | 1.52% | $152.40 | 147K | $33.5M |
| 9 | MOAltria Group | Consumer Defensive | 1.52% | $152.27 | 425K | $33.4M |
| 10 | REGNRegeneron Pharmaceuticals | Healthcare | 1.51% | $151.17 | 35K | $33.2M |
| 11 | BKNGBooking | Consumer Cyclical | 1.48% | $148.21 | 204K | $32.6M |
| 12 | UBERUBER Technologies | Technology | 1.46% | $145.54 | 459K | $32.0M |
| 13 | TMUST-Mobile US | Communication Services | 1.40% | $140.48 | 182K | $30.9M |
| 14 | APPAppLovin | Technology | 1.38% | $138.25 | 74K | $30.4M |
| 15 | CICigna Group/The | Healthcare | 1.37% | $136.80 | 101K | $30.0M |
of the $480B in 83 Value ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ACN | Accenture | 2.11% |
| 2 | ABBV | AbbVie | 2.00% |
| 3 | UNH | UnitedHealth Group | 2.00% |
| 4 | MRK | Merck & | 1.86% |
| 5 | CMCSA | Comcast | 1.84% |
| 6 | CRM | Salesforce | 1.76% |
| 7 | MPC | Marathon Petroleum | 1.65% |
| 8 | LOW | Lowe's Cos | 1.52% |
| 9 | MO | Altria Group | 1.52% |
| 10 | REGN | Regeneron Pharmaceuticals | 1.51% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 25, 2026 | $0.17 |
| Jun 25, 2026 | Jun 26, 2026 | $0.18 |
| Mar 26, 2026 | Mar 27, 2026 | $0.19 |
| Dec 29, 2025 | Dec 30, 2025 | $0.19 |
| Sep 24, 2025 | Sep 25, 2025 | $0.18 |
| Jun 25, 2025 | Jun 26, 2025 | $0.19 |
| Mar 26, 2025 | Mar 27, 2025 | $0.21 |
| Dec 27, 2024 | Dec 30, 2024 | $0.23 |
| Sep 25, 2024 | Sep 26, 2024 | $0.15 |
| Jun 26, 2024 | Jun 27, 2024 | $0.20 |
| Mar 20, 2024 | Mar 22, 2024 | $0.15 |
| Dec 27, 2023 | Dec 29, 2023 | $0.22 |